NIH: Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)RFA-CA-18-018
Sponsor: NIHInternal Deadline: 09/10/2018Institutional Submission Limit: 1Sponsor Deadline: 10/15/2018Program WebsiteNIH: Prevention of HPV-related Cancers in HIV-infected individuals: United States-Latin American-Caribbean Clinical Trials Network: Partnership Centers (U54 Clinical Trial Required)RFA-CA-18-018
This FOA encourages applications that facilitate the design, conduct, and completion of clinical trials for improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals. To serve this goal, the FOA will support a network of international collaborative sites conducting meritorious and appropriately designed prevention clinical trials in the Latin American and Caribbean (LAC) region via a U54 Partnership Centers mechanism.
USC may only submit only one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (firstname.lastname@example.org) by September 10, 2018. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is due by October 15, 2018 and a completed application is due by November 15, 2018. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-018.html